Latest filing published 10 Sept 2019 for Aldeyra Therapeutics, Inc., €23k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +17.9%Entry US$5.75 · Close at T+365 US$6.78
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David J. Clark: trading record in brief
David J. Clark appears in our data through filings on Aldeyra Therapeutics, Inc. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 29 December 2017 and the latest from 6 September 2019.
On the market, this insider has only ever bought: 1 purchase, €23k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants. Since January 2019: 1 purchase and no sales on the market.
On 10 September 2019 came the latest disclosure, an open-market purchase for €23k in Aldeyra Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David J. Clark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$5.06100.0% of flowCommon StockSEC:0000899243-19-023265:0Canonical exit: 5 Dec 2019 (T+90)
- 3,503 shares0Common StockSEC:0000899243-19-006730:0
- 4,774 shares@ US$4.0041.1% of flowCommon StockSEC:0000899243-18-006818:0
3 of 3 declarations
